---
title: "HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291318873.md"
description: "HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study"
datetime: "2026-06-30T17:45:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291318873.md)
  - [en](https://longbridge.com/en/news/291318873.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291318873.md)
generator: "portal-rs"
---

# HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study


### Related Stocks

- [BEAT.US](https://longbridge.com/en/quote/BEAT.US.md)

## Related News & Research

- [HeartBeam Buy Rating Reiterated as Clinical and Commercial Momentum Strengthens; $2 Price Target Maintained](https://longbridge.com/en/news/296257396.md)
- [HeartBeam posts Q2 presentation outlining heart attack detection progress and initial commercial launch traction](https://longbridge.com/en/news/295840063.md)
- [Cardio Diagnostics report flags widening rural cardiovascular care gap as workforce shortages persist](https://longbridge.com/en/news/297046313.md)
- [Affirm Beat Last Quarter's EPS Estimate by 76% — Can It Repeat That Thursday?](https://longbridge.com/en/news/297174910.md)
- [Heartflow FFRCT trial data show 44% drop in unnecessary invasive heart catheterizations](https://longbridge.com/en/news/297276738.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**